[go: up one dir, main page]

BRPI0407652A - método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição - Google Patents

método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição

Info

Publication number
BRPI0407652A
BRPI0407652A BRPI0407652-4A BRPI0407652A BRPI0407652A BR PI0407652 A BRPI0407652 A BR PI0407652A BR PI0407652 A BRPI0407652 A BR PI0407652A BR PI0407652 A BRPI0407652 A BR PI0407652A
Authority
BR
Brazil
Prior art keywords
composition
active agent
effectiveness
producing
enhancing
Prior art date
Application number
BRPI0407652-4A
Other languages
English (en)
Inventor
Isabelle Hansenne
Marc Cornell
Hani Fares
Peter Foltis
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BRPI0407652A publication Critical patent/BRPI0407652A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA ACENTUAR A EFICáCIA DE UM AGENTE ATIVO, COMPOSIçãO E MéTODO PARA PRODUZIR A COMPOSIçãO". A presente invenção refere-se a composições que contêm pelo menos um derivado de ácido salicílico e pelo menos um agente ativo cosmético, dermatológico, farmacêutico, etc., onde o derivado de ácido salicílico aumenta, acentua, etc., a eficácia do agente ativo, bem com ao métodos de produção e uso de tais composições. A invenção também se refere a um método para acentuar a eficácia de agentes ativos com esses derivados de ácido salicílico.
BRPI0407652-4A 2003-02-19 2004-02-06 método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição BRPI0407652A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/367,700 US8343519B2 (en) 2003-02-19 2003-02-19 Chemical enhancer and method
PCT/EP2004/001169 WO2004073745A1 (en) 2003-02-19 2004-02-06 Salicylic acid derivative as efficacy enhancer and method

Publications (1)

Publication Number Publication Date
BRPI0407652A true BRPI0407652A (pt) 2006-02-21

Family

ID=32850027

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407652-4A BRPI0407652A (pt) 2003-02-19 2004-02-06 método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição

Country Status (5)

Country Link
US (1) US8343519B2 (pt)
EP (1) EP1594546A1 (pt)
JP (1) JP2007523832A (pt)
BR (1) BRPI0407652A (pt)
WO (1) WO2004073745A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161392A1 (en) * 2003-02-19 2004-08-19 L'oreal S.A. Skin peeling composition and method
WO2007031117A1 (en) * 2005-04-19 2007-03-22 L'oreal Use op a lipophilic salicylic acid derivative as a deodorant active agent, process for treating body odour
FR2884416B1 (fr) * 2005-04-19 2007-06-15 Oreal Utilisation comme actif deodorant d'un derive lipophile de l'acide salicylique dans une composition deodorante ne contenant pas d'agent antitranspirant ; procede de traitement des odeurs corporelles
FR2884417B1 (fr) * 2005-04-19 2007-06-15 Oreal Composition cosmetique deodorante comprenant 'association d'un derive lipophile de l'acide salicylique et d'un sel d'aluminium anti-transpirant
US20070025939A1 (en) * 2005-07-29 2007-02-01 L'oreal S.A. cosmetic compositions containing hydroquinone and various sunscreen agents
US20090263340A1 (en) * 2006-04-18 2009-10-22 Dsm Ip Assets B.V. Cosmetic compositions
US8562574B2 (en) * 2006-10-02 2013-10-22 Gary S. Wallach Callus-tissue-debridement apparatus
US20080082058A1 (en) * 2006-10-02 2008-04-03 Wallach Gary S Debriding Callus Foot Tissue
GB2464430B8 (en) * 2007-07-20 2011-12-21 Rohto Pharma Emulsified composition
FR2936705B1 (fr) 2008-10-08 2010-12-17 Oreal Procede de rasage utilisant des derives de l'acide salicylique
JP5615515B2 (ja) * 2009-05-26 2014-10-29 持田製薬株式会社 洗浄用組成物
USD688798S1 (en) 2010-10-08 2013-08-27 Gary S. Wallach Debridement tool
FR2990850B1 (fr) * 2012-05-25 2014-05-16 Oreal Composition cosmetique comprenant l'association d'un derive lipophile de l'acide salicylique, d'un sel ou complexe d'aluminium anti-transpirant et d'un sel d'acide amine n,n-diacide acetique
FR3012960B1 (fr) 2013-11-13 2016-07-15 Oreal Utilisation comme agent deodorant d'un derive salifie d'acide salicylique, seul ou en melange
CN110099668A (zh) * 2016-12-22 2019-08-06 欧莱雅 包含4-(3-乙氧基-4-羟基苯基)-2-丁酮的防腐剂及其在化妆品组合物中的用途
CN109966241A (zh) * 2019-04-16 2019-07-05 浙江大学 一种促渗组合物在外用制剂经皮促渗中的应用
CN111559962B (zh) * 2020-07-14 2020-10-30 江西中医药大学 一种具有抗氧化活性的新酚酸类化合物的制备方法及应用
US12064504B2 (en) 2021-10-31 2024-08-20 L'oreal Cosmetic compositions comprising high amounts of trifluoromethylhenyl valylglycine
US12090224B2 (en) 2021-10-31 2024-09-17 L'oreal Cosmetic composition comprising high amounts of ceramide-np

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5389677B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
LU87187A1 (fr) 1988-03-31 1989-10-26 Oreal Association de derives de pyrimidine et de derives d'acide salicylique pour induire et stimuler la croissance des cheveux et diminuer leur chute
LU87408A1 (fr) 1988-12-16 1990-07-10 Oreal Utilisation de derives salicyles pour le traitement du vieillissement de la peau
FR2653336B1 (fr) 1989-10-20 1994-04-08 Oreal Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
BR9001880A (pt) 1990-04-18 1991-11-12 Forjas Taurus Sa Mecanismo de desarme do cao aplicavel a pistolas semi-automaticas
EP0570230B1 (en) 1992-05-15 1998-09-30 Shiseido Company Limited External preparation for skin
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
FR2714599B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition pour lutter contre le vieillissement, agissant siimultanément sur les couches superficielles et profondes de la peau, son utilisation.
FR2714831B1 (fr) 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés.
FR2718640B1 (fr) 1994-04-18 1996-05-15 Oreal Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations.
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
US5687971A (en) 1995-07-07 1997-11-18 Wascana Gaming Inc. Bingo game management method
FR2740040B1 (fr) 1995-10-23 1997-12-05 Oreal Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p
US6159479A (en) 1997-09-16 2000-12-12 L'oreal Hydrous salicylic acid solutions
FR2768622B1 (fr) 1997-09-22 1999-11-26 Oreal Extrait de rosacees en tant qu'antagoniste de bradykinine
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
CN1195475C (zh) 1999-09-06 2005-04-06 上田说子 化学去皮剂
US6566020B2 (en) * 2001-04-27 2003-05-20 Advanced Micro Devices, Inc. Dark field trench in an alternating phase shift mask to avoid phase conflict

Also Published As

Publication number Publication date
EP1594546A1 (en) 2005-11-16
US8343519B2 (en) 2013-01-01
WO2004073745A1 (en) 2004-09-02
JP2007523832A (ja) 2007-08-23
US20040162272A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
BRPI0409516A (pt) composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico
EE9700146A (et) Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
BR0212689A (pt) Composição fungicida, método de controle e produto
PE20001032A1 (es) Composiciones y metodos para tratar enfermedades pulmonares
BR9506452A (pt) Composto heterocíclico processo de preparação do composto heterocíclico composição farmacêutica composição farmacêutica adequada para o tratamento de inflamação neurogênica processo de tratamento de inflamação neurogênica em um individuo necessitado de tal tratamento e uso de um composto heterocíclico
DE60130135D1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
BRPI0701684A (pt) composição cosmética ou farmacêutica, processo de tratamento cosmético, uso de um composto e composto
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
BR0311222A (pt) R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos
ES2187125T3 (es) Compuestos biciclicos-aromaticos y su utilizacion en medicina humana o veterinaria asi como en cosmetologia.
NO20052494L (no) Preparater inneholdende melatonin, gingko biloba og biotin.
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
GT200400134A (es) Sistemas emulsionantes que contienen derivados de azetidina
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
BR0312179A (pt) Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
BR0104389A (pt) Processos para promover pele clara
DE60231385D1 (de) Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15V Prolongation of time limit allowed

Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E CONCEDIDO A DEVOLUCAO DE PRAZO DE 47 DIAS , NOS TERMOS DO ARTIGO 221 2O DA LPI E DA RESOLUCAO 116/04.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 10A E 11A ANUIDADES.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/67 (2006.01), A61K 8/34 (2006.01), A61K 8/3